Jonathan Weiss

发表

Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

William Pao, Thomas Zander, Martin Peifer, 2009, Proceedings of the National Academy of Sciences.

Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.

Hanmin Lee, Aaron B Caughey, Dick Oepkes, 2012, American journal of obstetrics and gynecology.

Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine

Thomas John, Vivek Rathi, Alexander Dobrovic, 2014, Oncotarget.

Analysis of Compound Synergy in High-Throughput Cellular Screens by Population-Based Lifetime Modeling

Martin Peifer, Daniel Rauh, Jörg Rahnenführer, 2010, PloS one.

The WNT receptor FZD7 contributes to self-renewal signaling of human embryonic stem cells

Jürgen Hescheler, Holm Zaehres, J. Hescheler, 2008, Biological chemistry.

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

Laura Tolosi, Michael Peyton, Thomas Zander, 2009, The Journal of clinical investigation.

ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors

William Pao, Michael Hölzel, Martin Peifer, 2011, Clinical Cancer Research.

Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation.

Martin Peifer, Daniel Rauh, Lars Ruddigkeit, 2010, Cancer research.

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations

Alexander Dobrovic, A. Dobrovic, A. Behren, 2015, Scientific Reports.

Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia

Viktor Achter, Ulrich Lang, Martin Peifer, 2018, Nature Communications.